Acquisition of independence from anchorage to the extracellular matrix is a critical event for onset and progression of solid cancers. To identify and characterize new genes conferring anchorage independence, we transduced MCF10A human normal breast cells with a retroviral cDNA expression library and selected them by growth in suspension. Microarray analysis targeted on library-derived transcripts revealed robust and reproducible enrichment, after selection, of cDNAs encoding the scaffolding adaptor Gab2. Gab2 was confirmed to strongly promote anchorageindependent growth when overexpressed. Interestingly, downregulation by RNA interference of endogenous Gab2 in neoplastic cells did not affect their adherent growth, but abrogated their growth in soft agar. Gab2-driven anchorage independence was found to specifically involve activation of the Src-Stat3 signaling axis. A transcriptional 'signature' of 205 genes was obtained from GAB2-transduced, anchorageindependent MCF10A cells, and found to contain two main functional modules, controlling proliferation and cell adhesion/migration/invasion, respectively. Extensive validation on breast cancer data sets showed that the GAB2 signature provides a robust prognostic classifier for breast cancer metastatic relapse, largely independent from existing clinical and genomic indicators and from estrogen receptor status. This work highlights a pivotal role for GAB2 and its transcriptional targets in anchorage-independent growth and breast cancer metastatic progression.
Introduction
Normal epithelial cells integrate signals from soluble ligands, such as growth factors (GFs), cytokines and hormones, with signals derived from the binding of transmembrane integrins to the extracellular matrix (ECM), to ensure that they only proliferate in the 'correct' social context (Berrier and Yamada, 2007) . Joint integrin/GF signaling is required for cell proliferation and for optimal cell survival: cell adhesion enhances GF-dependent responses, such as cell proliferation, migration and/or protection from apoptosis (Miranti and Brugge, 2002) . Conversely, cell detachment results in cellular desensitization to GF receptor signaling (Schwartz and Baron, 1999) . Moreover, signals evoked by integrins and GFs are widely integrated at the cellular level, as both impinge on an overlapping set of cytoplasmic signaling pathways (Berrier and Yamada, 2007) . Dependence on this reciprocal cross talk is progressively lost by transformed cells during the formation and spread of tumors (Guo and Giancotti, 2004) , and the acquisition of anchorage independence is considered to be a crucial step during cancer progression toward invasion and metastasis (Tsatsanis and Spandidos, 2004) . Therefore, the identification of genes or proteins promoting this step could provide novel targets or rationales for anticancer therapy. Among the possible ways for a genome-wide functional survey aimed at this scope are screenings based on the gain-of-function approach. Such screenings proved extremely valuable in the identification of genes involved in key cancerrelated processes, such as neoplastic transformation, resistance to apoptosis or escape from senescence (Kitamura et al., 2003) . As a screening model, we chose MCF10A cells, a spontaneously immortalized human breast line (Soule et al., 1990 ) that relies on both GFs and anchorage to proliferate. When these cells are cultured in the absence of anchorage, for instance on polyhema-coated plates, they undergo growth arrest and detachment-induced apoptosis, also known as anoikis (Reginato et al., 2003) . It was previously shown that the low transforming potential of these cells renders them well suited to monitor the effects of genes conferring oncogenic properties (Debnath and Brugge, 2005) . Therefore, MCF10A cells represent an ideal model to screen for genes conferring anchorage independence. For the screening, we exploited a novel approach, named 'Xenoarray analysis,' based on the transduction of mammalian cells of a given species with an expression library from another species, followed by one-shot quantitative tracing with DNA microarrays of library-derived transcripts before and after a selective stress, to disclose genes conferring resistance to the selection (Martelli et al., 2008) . After transduction with a mouse testis retroviral expression library, MCF10A cells were selected for growth in suspension and murine microarrays were used to compare signal intensities for the exogenous cDNAs, before and after selection, to detect the enriched ones. Independent infection and selection experiments highlighted significant and reproducible enrichment for murine Gab2-encoding transcripts, suggesting a role for this gene in anchorage-independent growth. Through biochemical studies, cell-based assays and genomic analysis, we found that Gab2 promotes anchorage-independent growth of normal and neoplastic cells, and drives a transcriptional program linked to the metastatic progression of breast cancer.
Results

Setup of a gain-of-function screening for anchorage independence in MCF10A cells
For the functional screening, MCF10A cells were transduced with a commercial mouse testis retroviral expression library (Stratagene, La Jolla, CA, USA) or with green fluorescent protein (GFP) as a control. To increase the screening robustness, infections were performed in duplicate (A and B), using an estimated multiplicity of infection of 1, to avoid multiple integrations in the same cell. To detect and quantify libraryderived transcripts, we performed Xenoarray analysis (Martelli et al., 2008) , by extracting total RNA from the four cell populations and hybridizing the resulting cRNAs on murine expression arrays, to allow specific detection of library-derived transcripts of murine origin. Expression measurements obtained, for infections A and B, in GFP-transduced cells (x axis) versus librarytransduced cells were compared by scatter plot analysis (Supplementary Figure 1) . Both library-transduced populations clearly showed a consistent number of detectable murine transcripts (945 and 1125 probes in infections A and B, respectively, with a detection P-value o0.01). Conversely, very few probes (around 100) cross-hybridized to endogenous transcripts and were also detected in GFP-transduced cells. On the basis of our previous observations on Xenoarray analysis sensitivity (Martelli et al., 2008) , we estimated that a selection-driven 20-fold enrichment of even a rare transcript, bringing it from 8 to 160 p.p.m., should be enough to render it clearly detectable by Xenoarray analysis.
We exploited the anchorage dependence of MCF10A cells for a selective screening based on culturing GFPor library-transduced cells on polyhema-coated plates. The four transduced populations were each split into two sublines: one was grown in adherence, and the other underwent six cycles of selection, each cycle consisting of 48 h of culture on polyhema followed by 24 h of recovery on regular plates. Cells recovered from GFPand library-transduced cells after selection were named 'GFP-SEL' and 'LIB-SEL,' respectively, and assayed for their ability to grow in the presence or absence of anchorage. LIB-SEL, but not GFP-SEL, cells displayed a significantly higher growth rate than unselected cells in both adherence and suspension ( Figure 1a) . Moreover, as shown in Figures 1b and c , only LIB-SEL cells could form large colonies in soft agar, an in vitro hallmark of cell transformation. These findings confirmed a 'library effect' not explainable with insertional mutagenesis but likely deriving from the expression of advantageous exogenous transcripts. Gab2 promotes anchorage-independent growth A Mira et al Identification by 'Xenoarray' analysis of cDNAs conferring anchorage independence on MCF10A cells To identify library-derived transcripts promoting anchorage-independent growth, we conducted Xenoarray analysis on library-transduced cells, before and after selection (Supplementary Figure 2) . A significant number of probes displayed a higher signal in selected cells, indicating that cells expressing the respective transcripts were enriched by the selection. To identify the genes that were reproducibly enriched in both selections, we calculated, for each transcript, the Log(2) ratio of the signal before and after selection. Interestingly, the Gab2 transcript showed a strong enrichment in both selections (average enrichment ¼ 14-fold). The enrichment was observed with three different probes, each designed in a different region of the Gab2 transcript. Other genes, including Ntrk3 and Cyp11a1, displayed a stronger enrichment in selection A (41-and 49-fold, respectively, in selection A, and 2-and 1.3-fold in selection B). Quantitative real-time PCR analysis with mouse-specific primers confirmed that Gab2 was the most enriched transcript, followed by Cyp11a1 and Ntrk3 (Figure 2a) . Therefore, we focused on this gene and also validated its enrichment at the protein level (Figure 2b ), thereby showing that the exogenous cDNA enriched after the selection actually encodes the full-length Gab2 protein. Exogenous Gab2 was found to be essential for anchorage-independent growth of the LIB-SEL population, as its downregulation by RNA interference strongly reduced the growth advantage of LIB-SEL cells, in adhesion, in suspension and in soft agar (Supplementary Figure 3) .
Validation and characterization of Gab2-driven anchorage independence Gab2 is a scaffolding/docking protein involved in multiple signaling pathways downstream from membrane receptors (Nishida et al., 1999) . To directly assess whether Gab2 may promote anchorage-independent growth, we transduced MCF10A cells with the human Gab2 coding sequence, cloned in a retroviral vector (gift of R Daly; Brummer et al., 2006) . The levels of exogenous Gab2 were comparable with those observed in the LIB-SEL population (Supplementary Figure 4) . As shown in Figure 3a , adherent Gab2-overexpressing cells showed a significant increase in proliferation, which was further enhanced in the absence of anchorage. It is noted that Gab2-driven growth advantage was almost totally lost when cells were kept in starving medium (no epidermal growth factor (EGF), and serum lowered to 2%), indicating that Gab2 promotes proliferation independently from cell anchorage to the ECM, but dependently from the presence of GFs and/or serum. Accordingly, Gab2-overexpressing cells formed larger and more abundant colonies in soft agar, compared with 
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A Mira et al wild-type (WT) cells ( Figure 3b ). Anchorage independence of Gab2-transduced MCF10A cells was again abrogated by Gab2 downregulation through RNA interference (Supplementary Figure 5) . To evaluate whether Gab2 promotes survival of detached cells, we estimated the fraction of dead cells after 48 h of suspension culture. Surprisingly, after 48 h of polyhema plating, we detected a comparable extent of cell death between WT and Gab2-expressing cells (Figure 3c ). These data indicate that Gab2 is not involved in the protection of MCF10A cells from anoikis, but rather allows their proliferation in the absence of adhesion to the ECM.
Gab2-driven anchorage independence requires Src and involves Stat3
Previous analyses have identified signaling molecules that can bind to Gab2 on receptor activation, including the tyrosine phosphatase Ptpn11/Shp2, leading to the activation of Erk and Jnk (Yu et al., 2006) , the p85 subunit of PI3K, leading to Akt activation (Bouscary et al., 2001) , and Src family kinases (Kong et al., 2003) . Therefore, to dissect the signaling pathways downstream of Gab2 that could mediate anchorage-independent growth, we examined the effects on cell vitality of a panel of small molecule inhibitors targeting the abovementioned signaling kinases ( Figure 4a ). The PI3K inhibitor was the most effective, but with no differential between anchorage-dependent and -independent growth, or between control and Gab2-expressing cells, showing a general requirement of this pathway for survival of MCF10A cells. A similar but less pronounced effect was observed for Mek inhibition. The Jnk inhibitor displayed modest effects in all conditions. Interestingly, the Src inhibitor PP2 displayed the highest specificity toward Gab2-expressing cells in suspension.
A more detailed analysis of the effects of Src inhibition is shown in Figure 4b . According to these data, Gab2-driven anchorage independence requires Src, which typically is activated by integrins when cells are adherent and becomes inactivated on detachment (Playford and Schaller, 2004) . Consistently, western blot analysis on cell lysates from control and Gab2-expressing cells cultured in adhesion or suspension confirmed Gab2-driven activation of Src and of one of its downstream targets, Stat3 ( Figure 4c ). In adhesion, Gab2-expressing cells displayed a stronger basal phosphorylation of Src. Active Src levels were reduced in cells kept in suspension, but although in control cells Src activation was completely abolished at 48 h, Gab2-expressing cells maintained some phosphorylation. Analysis of Stat3 activation highlighted an even more pronounced response to Gab2 expression, indicating the capacity of Gab2 to also sustain the activation of Stat3 in the absence of a substratum consensus. As many studies provided evidence for Stat3 involvement in Srcmediated oncogenesis (Yu et al., 1995) and anchorageindependent growth (Laird et al., 2003) , these data indicate that Gab2 could signal through Src and Stat3 to accomplish anchorage-independent growth.
Endogenous Gab2 is essential for anchorage-independent growth of normal and neoplastic cells
The data presented so far show that constitutive, exogenous expression of Gab2 promotes anchorageindependent growth. To verify whether this effect is Figure 6) . In MCF10A cells, Gab2 silencing markedly reduced their growth both in adhesion and in suspension (Figure 5a ), whereas both MDA-MB-231 breast cancer cells and MDA-MB-435 melanoma cells responded to Gab2 silencing with a significant but modest reduction of proliferation (Figure 5b ), indicating a minor role for Gab2 in the presence of attachment. Strikingly, however, the ability of these cells to form colonies in soft agar was completely abrogated by Gab2 silencing (Figure 5c ). In accordance with our previous western blot data, Gab2 loss determined a significant and concomitant decrease in Src and Stat3 activation (Figure 5d ). Interestingly, the most evident reduction of Src-Stat3 phosphorylation was observed for MDA-MB 231 cells, which endogenously express the highest levels of Gab2 and most strongly reduce their soft agar growth on Gab2 silencing. Altogether, these data confirmed the Gab2-Src-Stat3 axis as a key promoter of anchorage-independent growth of neoplastic cells.
A GAB2 transcriptional signature correlates with breast cancer aggressiveness To gain further insights on Gab2-driven anchorageindependence, we performed gene expression profiling on MCF10A cells transduced with GAB2 and selected by growth in the absence of anchorage. As control, we used RNA extracted from GFP-transduced and -selected cells. The selection was performed as described for the library-transduced cells. As further controls, GFP-and GAB2-transduced cells were also profiled before the selection, together with WT MCF10A cells. Statistical analysis was applied to retrieve genes differentially expressed between GAB2-transduced and GFP-transduced cells after the selection (see Supplementary Methods), highlighting 221 probes, corresponding to 205 independent genes: the 'GAB2-signature' (Supplementary Table 1 ). The signature revealed a significant enrichment (Po2.5 Â 10
À5
) in genes related to cell proliferation (also highlighted in Supplementary Table 1) . Interestingly, the GAB2 signature was also significantly enriched in genes whose expression correlates with sensitivity of the NCI-60 panel of neoplastic cell lines 
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), small molecules that inhibit STAT3 activation by Src, Jak or other tyrosine kinases (see Supplementary Methods and Supplementary  Table 2 ). These results confirm that the Src-STAT3 signaling axis has a key role in Gab2-driven biological and transcriptional responses independent of tissue and cell type. To extend the value of the in vitro model of Gab2-driven anchorage independence, we verified whether the GAB2 signature could be associated with human breast cancer aggressiveness. To this aim, the signature was mapped on a 311-sample breast cancer data set generated at the Netherland Cancer Institute on 2-color oligonucleotide microarrays (NKI data set) and published in two works (van de Vijver et al., 2002; van 't Veer et al., 2002) . After filtering for expression, the GAB2 signature was mapped to 150 probes. Interestingly, the signature resulted in strong enrichment of genes discriminating between breast cancer patients with or without metastatic recurrence within 5 years from the initial diagnosis (Po10
À8
; see Supplementary Methods). On the basis of these results, using the nearest mean classifier approach (Wessels et al., 2005) , we built a classifier in the NKI data set, based on the entire GAB2 signature, which provides a 'metastasis score,' discriminating between patients with good and poor prognosis (Supplementary Methods and Supplementary Table 3) . Data clustering and mining revealed two specific gene functional modules associated with prognosis: (i) a sizable proliferation module positively correlated with metastatic progression, and (ii) an interesting module composed of negative regulators of cell-matrix interaction, migration and invasion, expressed at higher levels in good prognosis samples (Figure 6a and Supplementary Table 4) .
To validate the classifier, we mapped it on two independent data sets of 198 and 236 samples, both obtained on Affymetrix microarrays and aimed at evaluating metastasis-free survival (Desmedt et al., 2007) and death of disease (Miller et al., 2005) . In both cases, the GAB2 signature classified patients with high accuracy, despite the change of microarray platform (Figures 6b and c) . We then applied the GAB2 signature on the 198-sample data set stratified by various clinical and genomic classifiers originally provided in the work. When samples were subdivided by their prognostic class according to the Adjuvant!Online score (Hess, 2008) , they could still be further subdivided into good-and poor-prognosis subgroups by the GAB2 signature (Figures 7a and b) . Similarly, the signature also correctly reclassified samples previously subdivided into good-and poor-prognosis subgroups by genomic classifiers, such as the 76-gene 'Veridex Index' (Desmedt et al., 2007) (Figures 7c and d) and the 70-gene 'Mammaprint' classifier (Buyse et al., 2006) (Figures 7e and f) . These results show that the GAB2 signature predicts the metastatic relapse of breast cancer independently of existing clinical and genomic classifiers. Such independence was further confirmed by univariate and multivariate statistics calculated, on the 198-sample data set, for the GAB2 signature versus Adjuvant!Online or three published genomic prognostic classifiers Veridex index, MammaPrint and 'Genomic Grade Index' (Sotiriou et al., 2006) (Table 1 and Supplementary Methods). Reciprocal significance impairment was observed only with the Mammaprint classifier, which, however, is obtained on a proprietary microarray platform, whereas the GAB2 signature can be directly tested on all publicly available Affymetrix microarray data sets. Finally, the GAB2 signature was found to also maintain prognostic ability in samples subdivided by estrogen receptor status (Figures 7g  and h ). Intriguingly, a small fraction of the estrogen receptor-negative samples was called 'good prognosis' with 100% precision, but with no statistical significance probably because of the limited number (64) of samples analysed. We therefore added samples from two other data sets (Wang et al., 2005; Ivshina et al., 2006) , reaching a total of 175 estrogen receptor-negative samples, for which the GAB2 signature maintained 100% precision and reached statistical significance (Supplementary Figure 7) .
Discussion
To ensure successful metastatic dissemination, malignant cells must acquire the ability to grow in the absence of their environment of origin. In fact, the capacity of cells to survive and proliferate in vitro in the absence of integrin-mediated adhesion strongly correlates with tumorigenesis in vivo and may enable tumor cells to metastasize and grow at inappropriate sites in the body (Danen and Yamada, 2001) . We hereby describe a key role in anchorage-independent growth for Gab2, a multiadaptor protein devoid of enzymatic activity. The role of Gab2 in anchorage-independent growth emerged within the context of a high-throughput selective functional screening, in which this protein competed with several thousand others. Apart from GAB2, the analysis also revealed a reproducible enrichment for a well-known transforming gene, NTRK3, previously found to have a key role in anoikis resistance (Geiger and Peeper, 2007) and useful as an internal control of the screening effectiveness. Gab2 is a member of the Grb2-associated binding protein gene family (Gu et al., 1998) . They are called 'scaffolding' or 'docking' proteins because of the presence of multiple functional motifs mediating interactions with many other signaling molecules (Nishida et al., 1999) . Grb2-associated binding proteins are involved in signaling events triggered by a variety of stimuli, including GFs, cytokines, G-coupled receptors and T-and B-lymphocyte antigens, ultimately regulating cell growth, differentiation and transformation (Bouscary et al., 2001; Liu et al., 2001; Sattler et al., 2002) . Among the Gab2 direct interactors are proteins with key roles in human cancer when mutated, such as PI3K and the tyrosine phosphatase Ptpn11/Shp2. A recent work has suggested that the oncogenic properties of Ptpn11 mutant proteins require signal enhancement by Gab2 (Zatkova et al., 2006) . Interestingly, GAB2 maps to a chromosomal region (11q13) amplified in 10-15% of breast cancers, and its Gab2 promotes anchorage-independent growth A Mira et al overexpression was confirmed in several breast cancer cell lines (Daly et al., 2002) . The role of Gab2 in mammary tumor metastasis was also explored and confirmed in mouse models (Ke et al., 2007) . More recently, a key role for this gene in the motility/invasion of melanoma cells and metastatic progression of melanoma was also highlighted (Horst et al., 2009) .
We now show that Gab2 promotes anchorage-independent growth of breast cancer and melanoma cells. This information extends the previously described growthpromoting activity of Gab2 in adherent cells (Brummer et al., 2006) . We also found that Gab2-driven anchorage independence is not due to a protection from cell death on detachment. This finding was unexpected, given the 
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A Mira et al fact that Gab2 potentiates the PI3K/Akt and Ras/Erk pathways, but it is in line with previous reports indicating that Gab2 does not prevent apoptosis of luminal cells during the morphogenesis of MCF10A cells (tires-Alj et al., 2006) . Our experiments using small molecule inhibitors showed that the PI3K/Akt and Ras/ Erk pathways are always required, regardless of the adhesion status and Gab2 expression, while Src inhibition had no effect on WT cells in suspension, but strongly impaired their adherent growth, confirming that Src conveys the proliferative consensus provided by integrin engagement (Playford and Schaller, 2004) . Moreover, Gab2-expressing cells also required Src activity in suspension, providing a strong rationale for Src involvement in Gab2-driven anchorage independence. The biochemical link between Gab2 and Src can be provided by Ptpn11, previously described to directly bind Gab2 (Kong et al., 2003) and to activate Src (Zhang et al., 2004) . It is of particular interest that Gab2-sustained growth in suspension was impaired when cells were cultured in the absence of EGF, indicating that Gab2 can only overcome the lack of adhesive consensus in the presence of an upstream signal from GFs. Recently, Gab2 was found to promote GF independence in cooperation with oncogenic Src (Bennett et al., 2007) . Therefore, Gab2 can rescue cells from the need for two concomitant proliferative stimuliactivated GF receptors and activated Src-when at least one of the two is present at sufficiently high levels. Therefore, Gab2 can be a key rheostat and integrator, allowing for a 'spillover' of the signal across the two pathways, in the context of a network containing points of reciprocal influence and cross talk (ffrench-Constant and Colognato, 2004) . In this view, the proliferation of non-adherent cells could be promoted by a GF-driven direct activation of the Erk and Akt pathways and indirect Gab2-mediated activation of Src and of its downstream signaling molecules, in particular Stat3. Indeed, Stat3 has already been involved in the Src-and Jak1-driven proliferation of human breast carcinoma cells (Garcia et al., 2001 ) and in the anchorageindependent growth of cancer cells (Zhang et al., 2006) . Moreover, Gab2 was found to contain a functional Stat3-binding motif promoting its recruitment and activation (Ni et al., 2007) . Our biochemical data confirmed the contribution of Src and Stat3 to Gab2-mediated anchorage-independent growth: Gab2 expression increased Src and Stat3 phosphorylation both basally and after prolonged suspension culture, and Gab2 downregulation by RNA interference led to the reduction of Src and Stat3 activation not only in MCF10A cells constitutively expressing exogenous Gab2, but also in neoplastic cells losing anchorage independence as a consequence of endogenous Gab2 silencing. In line with this, our gene expression analysis showed that a significant fraction of the genes whose expression is regulated by Gab2 is also differentially expressed in cancer cells resistant or sensitive to small molecule inhibitors of the Src/Jak1-STAT3 signaling axis. Finally, it is of particular significance that the GAB2 transcriptional signature yields a robust classifier for the metastatic relapse of human breast cancer. Of the two key functional modules found in the signature, the proliferation module, positively correlated with metastasis, adds further informative genes to the already described core of proliferation genes associated with breast cancer progression (Wirapati et al., 2008) . More distinctive is the module of genes negatively correlated with metastasis, among which particularly interesting are: (i) two extracellular proteins that inhibit matrixdegrading proteases (SERPINB1 (Cooley et al., 2001) ) and remove fucose from ECM glycans (FUCA1), thereby impairing ECM binding and invasion by cancer cells (Yuan et al., 2008) ; (ii) the FAP gene, encoding an integral membrane protease whose expression is negatively correlated with metastatic progression (Ariga et al., 2001) ; (iii) PMP22, that encodes a 4-spanning integral membrane protein widely expressed at the apical junctions of epithelial cells, increasing the Gab2 promotes anchorage-independent growth A Mira et al transepithelial electrical resistance and decreasing migration (Roux et al., 2005) ; (iv) the intracellular products of the ARHGDIB and SPRY1 genes, negative regulators of the Rho-family GTPases (DerMardirossian and Bokoch, 2005) and tyrosine kinase receptors, such as endothelial growth factor receptor and FGFR, respectively (Mason et al., 2006) . These two functional modules, within the context of the GAB2 signature, generate a prognostic classifier predicting metastatic progression with high accuracy, independent from the estrogen receptor status and from other existing genomic signatures, and greatly outperforming the clinical-pathological prognostic parameters currently integrated into the Adjuvant!Online web tool (Hess, 2008) . Altogether, this work defines a key role for Gab2 in the anchorage-independent growth of neoplastic cells and paves the way to prospective clinical validation of the GAB2 signature as a new, strong and independent prognostic classifier for breast cancer.
Materials and methods
Cell culture and reagents MCF10A cells were obtained from ATCC and cultured as described (Reginato et al., 2003) . MDA-MB-231 and MDA-MB-435 cells were obtained from ATCC and cultured in DMEM (Gibco, Frederick, MD, USA) supplemented with 10% fetal bovine serum (Sigma, St Louis, MO, USA). The antibodies used were as follows: anti-Gab2 (Upstate Biotechnology, Lake Placid, NY, USA), anti-Tyr416-phosphorylated Src (Cell Signaling, Boston, MA, USA), anti-total Src (Cell Signaling), anti-Tyr705-phosphorylated Stat3 (Cell Signaling), anti-total Stat3 (Cell Signaling), and goat anti-actin (Santa Cruz, Santa Cruz, CA, USA). Retroviral expression library and pFB-hrGFP retroviral supernatant, packaged in the VSV envelope, were purchased from Stratagene (ViraPort, Cat. no. 972300) and used to infect 1.5 Â 10 5 MCF10A cells in 60 mm tissue culture plates using 10 mg/ml DEAE-dextran (Amersham Bioscience, Little Chalfont, UK). GFP expression analysis was performed after 48 h using an FACS Calibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ USA). Retroviral expression vector for GAB2 in pMIG (also known as pMSCV-IRES-GFP) was a gift of R Daly. Virus production and transduction were performed as described (Brummer et al., 2006) . Lentiviral shRNA expression vectors against murine or human GAB2 were purchased from Sigma (MISSION TRC shRNA Target Set), together with the pLKO.1-puro Control Vector. Viral supernatants were obtained according to the manufacturer's protocol. Infected cells were selected by puromycin treatment (2 mg/ml for 1 week). Specific shRNA sequences that efficiently downregulated Gab2 protein, as assessed in western blot, were the following: (i) Murine: CCGGCCGACACAATACAGAATTCAACTCGAGTTGAAT TC-TGTATTGTGTCG-GTTTTTG; (ii) human: CCGGCAGC CAACTCTGTTCACGTTTCTC-GAGAAACGTGAACAGAG TTGGCTGTTTTTTG.
Xenoarray and gene expression analysis RNA was extracted using the Trizol Plus purification Kit (Invitrogen, Frederick, MD, USA, cat. no.12183555), according to the manufacturer's protocol. Quantification and quality analysis of RNA was performed on a Bioanalyzer 2100 (Agilent, Santa Clara, CA, USA). Synthesis of cDNA and biotinylated cRNA were performed using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin, TX, USA, cat. no. IL1791), according to the manufacturer's protocol, with previously reported variations in the case of Xenoarray analysis (Martelli et al., 2008) , for which hybridization was carried out on Illumina Mouse6_V1 arrays. For standard microarray analysis of the Gab 2 signature, 1500 ng of cRNAs were hybridized on Illumina Beadarrays (Human_6_V2). All microarray data are available at GEO GSE18237. To define genes associated with GAB2-driven anchorage independence, microarray data were normalized and filtered for expression and for not being differential between controls. Subsequently, statistical selection of differential genes was carried out as described in Supplementary Methods.
Anchorage-independent growth selection Polyhema-coated 10 cm Petri dishes were prepared by applying 4 ml of a 12 mg/ml solution of poly-hydroxy-ethyl-methacrylate (polyhema; Sigma) in ethanol, drying under tissue culture hood, repeating the application once and incubating the plates overnight at 37 1C. For the selection, 3 Â 10 6 cells were plated onto polyhema-coated plates in complete growth medium. Cells were cultured in suspension for 48 h and were then allowed to recover on regular plates for 24 h before repeating the selection cycle.
Western blot
Cell lysates from 2 to 5 Â 10 6 cells were prepared in RIPA buffer (150 mM NaCl, 1% NP40, 0.5% sodium desoxycholate, 50 mM Tris-HCL at pH 8, 0.1% SDS, 10% glycerol, 5 Mm EDTA, 20 mM NaF and 1 mM Na 3 VO 4 ) supplemented with 1 mg/ml each of pepstatin, leupeptin, aprotinin and 200 mg/ml phenyl methylsulphonyl fluoride. Lysates were cleared by centrifugation at 12 000 r.p.m. for 20 min at 4 1C and normalized with the BCA Protein Assay Reagent Kit (Pierce, Rockford, IL, USA). Extracts were run on SDS polyacrylamide gels, transferred onto nitrocellulose membranes (Hybond; GE Healthcare, Place Escondido, CA, USA) and incubated with different antibodies overnight at 4 1C. Nitrocellulose-bound antibodies were detected by the ECL system (GE Healthcare).
Real-time PCR
Two micrograms of total RNA were reverse transcribed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Quantitative Real-time PCR with Sybr Green was performed on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems, Oak Brook, IL, USA). Details on PCR primer design are available in Supplementary Methods.
Cell-based assays
For MTT cell growth assays, 10 3 cells were seeded in regular or polyhema-coated 96-well plates. Cells were cultured in growth medium containing all supplements or in starving medium (serum reduced to 2%, no endothelial growth factor). At the indicated times, a tetrazolium salt-based reagent (CellTiter96 Aqueous One Solution, Promega, Madison, WI, USA) was added to each well according to the instructions provided by the manufacturer. After an incubation of 2 h, absorbance was read at 490 nm on a DTX 880 plate reader (Beckman Coulter, Fullerton, CA, USA). A control measurement after 4 h from plating was used as a reference to adjust subsequent acquisitions of each cell line.
For soft agar growth, 3 Â 10 4 cells were resuspended in 2 ml of 0.5% top agar (SeaPlaque Agarose from Cambrex, East Rutherford, NJ, USA) in growth medium and seeded in sixwell plates previously filled with 3 ml of 1% basal agar in growth medium. The assay was performed in duplicate. After 3 weeks, phase-contrast pictures were captured by a BD Pathway microscopic station (BD Biosciences, Franklin Lakes, NJ, USA). Image analysis and quantification of single colonies number and size were performed by the Attovision 1.5 software (BD Biosciences).
For detachment-induced cell death analysis, 3 Â 10 5 cells were plated on regular or polyhema-coated 35 mm plates for 48 h. Cell death was then measured by assessing the number of hypodiploid nuclei with the DNAcon3 kit (ConsulTS, Rivalta, Italy), according to the manufacturer's protocol and with cytofluorimetric analysis using an FACSCalibur (Becton Dickinson). Hypodiploid, subG0/G1 nuclei were defined as those displaying a propidium iodide staining value lower than that of cells in the G0/G1 cell cycle phase (diploid DNA peak).
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